First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosaassociated lymphoid tissue lymphoma (MALT2008-01): A multicentre, single-arm, phase 2 trial

  1. Salar, A.
  2. Domingo-Domenech, E.
  3. Panizo, C.
  4. Nicolás, C.
  5. Bargay, J.
  6. Muntañola, A.
  7. Canales, M.
  8. Bello, J.L.
  9. Sancho, J.M.
  10. Tomás, J.F.
  11. Rodríguez, M.J.
  12. Peñalver, F.J.
  13. Grande, C.
  14. Sánchez-Blanco, J.J.
  15. Palomera, L.
  16. Arranz, R.
  17. Conde, E.
  18. García, M.
  19. García, J.F.
  20. Caballero, D.
  21. Montalbán, C.
Revista:
The Lancet Haematology

ISSN: 2352-3026

Ano de publicación: 2014

Volume: 1

Número: 3

Páxinas: e104-e111

Tipo: Artigo

DOI: 10.1016/S2352-3026(14)00021-0 GOOGLE SCHOLAR